More Than an Echo.
Less Than a Procedure.
NO CATH LAB NEEDED • POINT-OF-CARE ACCESSIBILITY • NON-INVASIVE DIAGNOSTICS • HEMODYNAMIC MONITORING • PULMONARY CARE • CARDIAC CARE • PORTAL HYPERTENSION
SonoVivo Inc is developing a solution to the overcrowded cath lab problem. Millions of cardiac and pulmonary hypertension patients go without concrete diagnostic data every year. For the few selected to receive the only acceptable procedure, they are subject to an invasive and potentially damaging right heart catheter exam. Our ultrasound based technology, in combination with a microbubble contrast agent, is being designed to test for the exact same diagnostic pressure measurements with the same level of accuracy.
Our Technology
Hemodynamic Pressure Sensing
Non-Invasive Protocol
Our proprietary point-of-care contrast-enhanced ultrasound will deliver instantaneous, high-fidelity hemodynamic pressure readings. By eliminating diagnostic wait times, we aim to enable rapid clinical decision-making vital for acute patient management.
Designed for simplicity and patient comfort, our protocols will expand access to critical diagnostic data for the 15M+ patients in the US who don't qualify for invasive catheterization.
Detection Logic
Cost Efficiency
Advanced diagnostic algorithms process hemodynamic data in real-time, identifying early markers of hypertension at targeted locations within the cardiovascular system. This proactive approach is being designed not only as an early detection tool, but to provide the option for serial monitoring of disease progression.
SonoVivo's technology will lower the barrier to high-quality diagnostics by drastically reducing overhead and diagnostic costs. Out goal is to provide accurate pressure readings with non-invasive simplicity at a fraction of standard procedure costs.
Projected Clinical Applications
Cardiac Pressures
Portal Hypertension
Cancer Detection
Providing instantaneous and non-invasive hemodynamic monitoring, our technology will enable rapid clinical decisions for acute cardiac patient management and assisting in diagnosis of pulmonary hypertension.
SonoVivo will offer measurement of the hepatic vein pressure gradient used diagnose portal hypertension, replacing invasive catheterization and enhancing provider workflows.
A long term application goal, is to offer early and repeatable detection of interstitial fluid pressure markers offers oncologists a critical new pathway for screening and treatment monitoring of arterialized solid tumors.
Anticipated Diagnostic Excellence & Strategic Impact
Transforming diagnostic pathways through safe, accessible, and instantaneous point-of-care procedures that redefine cardiac monitoring.
Non-Invasive Simplicity
Preventing critical complications related to invasive RHC procedures through early and accurate pressure detection POC scans.
Cost-Effective Diagnostics
Significantly reducing hospital system, payor, and patient costs by replacing expensive invasive procedures with accessible, non-invasive simpler alternatives.
Instantaneous Precision
Providing real-time pressure monitoring that allows clinicians to make immediate, life-critical decisions with complete diagnostic confidence.
Anticipated benefits of SonoVivo's SHARP technology.
Our Mission
At SonoVivo Inc, we are dedicated to transforming hemodynamic pressure diagnostics through non-invasive POC contrast-enhanced ultrasound scans. Our mission centers on providing healthcare professionals with precise, POC tools for instantaneous pressure monitoring, ensuring the early detection of complications and improving patient outcomes worldwide through innovation and risk free excellence.
Connect for Clinical Point-of-Care Excellence
We bridge the gap between invasive diagnostic procedures and non-invasive simplicity. Reach out for technical specifications, partnership inquiries, investing opportunities, or early-stage diagnostic integration protocols.
NO CATH LAB NEEDED • POINT-OF-CARE ACCESSIBILITY • NON-INVASIVE DIAGNOSTICS • HEMODYNAMIC MONITORING • PULMONARY CARE • CARDIAC CARE • PORTAL HYPERTENSION